fr en es de it pt nl

Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.

Resultaat van uw zoeken : 11 product gevonden

Verfijn uw zoekopdracht :

RUOCE / IVD

Biochemicals

WB 8

BRENG DE FILTERS AAN
INITIALISEREN

Referentie

Beschrijving

Cond.

Price Bef. VAT

MBS2086208-0,01mg

OVA conjugated Epidermal Growth Factor (EGF)

0.01mg

MBS2086208-0,2mg

OVA conjugated Epidermal Growth Factor (EGF)

0.2mg

MBS2086208-0,1mg

OVA conjugated Epidermal Growth Factor (EGF)

0.1mg

MBS2086208-1mg

OVA conjugated Epidermal Growth Factor (EGF)

1mg

MBS2086208-0,5mg

OVA conjugated Epidermal Growth Factor (EGF)

0.5mg

MBS2086208-5mg

OVA conjugated Epidermal Growth Factor (EGF)

5mg

MBS2086208-5x5mg

OVA conjugated Epidermal Growth Factor (EGF)

5x5mg

MBS2086208-0,05mg

OVA conjugated Epidermal Growth Factor (EGF)

0.05mg

orb1910500-1g

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

1g

orb1910500-100mg

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

100mg

orb1910500-250mg

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

250mg

‹

›